Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Tim Luke who wrote (4356)	12/30/1998 9:36:00 PM
From: Glenn	Respond to of 90042

I have been loosely following Abbot Labs, since we are on the topic of biotechs. I avoided them, as I didn't understand the companies as well as I did the high tech ones. I used to hear a lot about them about a year ago. Any thoughts here. Glenn

To: Tim Luke who wrote (4356)	12/30/1998 9:50:00 PM
From: Glenn	Read Replies (1) \| Respond to of 90042

The yahoo xyln thread is worth spending a couple of minutes checking out. Of course, it's unusually positive today, but I found it interesting anyway. Glenn messages.yahoo.com

To: Tim Luke who wrote (4356)	12/31/1998 12:43:00 AM
From: Jane4IceCream	Read Replies (2) \| Respond to of 90042

My bio/pharm trades as of late...... LIPO CYPH ASTM GERN IMNX ICOS IMNR AGPH I know bios/pharms. I live in the hot biotech valley between Carlsbad and San Diego along Pacific Coast Hwy and near Scripps Institute (Jonas Salk). With bios, its the story. The story, the pipeline, the products in trials and up for FDA approval, the partnerships, the distribution channels, the patents, the management, cash on hand for continuing research and development. With bios, its a much different game than the Internets or techs. A current favourite of mine I have been holding since around $5 is LIPO. Jane

To: Tim Luke who wrote (4356)	1/1/1999 9:43:00 AM
From: sam	Read Replies (1) \| Respond to of 90042

As Jane Jackson said, buying biotechs is an entirely different ballgame. The big biotechs: AMGN, AGPH, BGEN, IMNX are the safe bets. They can do it all. Invent compounds, develop them, and market them on their own. And they have all done very, very well recently. Others, such as CNTO, have a lot of support on Wall Street and make for great traders. In the smaller biotechs, I look for a killer pipeline of compounds preferably in the later stages of the FDA approval process, an ability to either obtain new killer compounds or invent them in house, a management team that's focused, smart and able to get proper financing to keep the company running through the unprofitable periods (without giving away the boat), partnering agreements with major pharms, and a development team that is successful at working a product through the FDA. There are potential homeruns, to be sure, but they take a long time to develop. Thus, there aren't many. And for every runnup, there's a boatload of shorters ready to take the stock down again. Look at Entremed to get a sense of what 'potential' in biotech can mean on any given day. I have invested a lot in biotechs recently, have traded some, but I totally agree with you that this could be a big year for many.